Colgate-Palmolive (NYSE:CL) Shares Sold by Stokes Capital Advisors LLC

Stokes Capital Advisors LLC trimmed its position in Colgate-Palmolive (NYSE:CL) by 4.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 66,433 shares of the company’s stock after selling 3,364 shares during the quarter. Stokes Capital Advisors LLC’s holdings in Colgate-Palmolive were worth $6,039,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. XTX Topco Ltd purchased a new position in Colgate-Palmolive during the 2nd quarter valued at about $423,000. Ieq Capital LLC lifted its holdings in shares of Colgate-Palmolive by 22.6% during the 2nd quarter. Ieq Capital LLC now owns 38,617 shares of the company’s stock valued at $3,747,000 after buying an additional 7,130 shares during the last quarter. AE Wealth Management LLC lifted its stake in Colgate-Palmolive by 70.9% in the second quarter. AE Wealth Management LLC now owns 22,607 shares of the company’s stock valued at $2,194,000 after acquiring an additional 9,382 shares during the last quarter. Sei Investments Co. boosted its holdings in Colgate-Palmolive by 1.8% in the second quarter. Sei Investments Co. now owns 609,139 shares of the company’s stock worth $59,111,000 after purchasing an additional 10,500 shares in the last quarter. Finally, Summit Trail Advisors LLC boosted its stake in shares of Colgate-Palmolive by 2.6% during the 2nd quarter. Summit Trail Advisors LLC now owns 5,490 shares of the company’s stock worth $533,000 after acquiring an additional 141 shares in the last quarter. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on the company. StockNews.com cut Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Thursday, January 9th. JPMorgan Chase & Co. decreased their price objective on shares of Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating for the company in a report on Thursday. TD Cowen dropped their target price on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a report on Wednesday, January 8th. UBS Group decreased their price target on shares of Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating for the company in a report on Thursday. Finally, Stifel Nicolaus dropped their price objective on Colgate-Palmolive from $101.00 to $95.00 and set a “hold” rating on the stock in a research note on Friday. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have given a buy rating to the company. According to MarketBeat, Colgate-Palmolive has a consensus rating of “Hold” and a consensus price target of $101.11.

Insiders Place Their Bets

In other news, CFO Stanley J. Sutula III sold 45,410 shares of Colgate-Palmolive stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the sale, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. This trade represents a 55.29 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.34% of the company’s stock.

Colgate-Palmolive Price Performance

Shares of CL stock opened at $88.79 on Monday. Colgate-Palmolive has a 52 week low of $79.69 and a 52 week high of $109.30. The stock has a market capitalization of $72.55 billion, a PE ratio of 25.44, a PEG ratio of 3.01 and a beta of 0.44. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04. The stock’s fifty day moving average is $92.20 and its 200-day moving average is $97.75.

Colgate-Palmolive Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be given a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 2.25%. The ex-dividend date of this dividend is Tuesday, January 21st. Colgate-Palmolive’s payout ratio is presently 57.31%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.